High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19 a randomised, placebo-controlled trial

Autor: Alemany, A, Millat-Martinez, P, Corbacho-Monne, M, Malchair, P, Ouchi, D, Ruiz-Comellas, A, Ramirez-Morros, A, Codina, JR, Simon, RA, Videla, S, Costes, G, Capdevila-Jauregui, M, Torrano-Soler, P, San Jose, A, Papell, GB, Puig, J, Otero, A, Suarez, JCR, Pellejero, AZ, Roca, FL, Cortez, OR, Garcia, VG, Vidal-Alaball, J, Millan, A, Contreras, E, Grifols, JR, Ancochea, A, Galvan-Femenia, I, Ferreira, FP, Bonet, M, Cantoni, J, Prat, N, Ara, J, Arcarons, AF, Farre, M, Pradenas, E, Blanco, J, Rodriguez-Arias, MA, Rivas, GF, Marks, M, Bassat, Q, Blanco, I, Baro, B, Clotet, B, Mitja, O

Publikováno v: Lancet Respiratory Medicine
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
LANCET RESPIRATORY MEDICINE
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

Background Convalescent plasma has been proposed as an early treatment to interrupt the progression of early COVID-19 to severe disease, but there is little definitive evidence. We aimed to assess whether early treatment with convalescent plasma redu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::77b8a4e176bcf3f212f5c1439ce359b4
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=9959

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Antibiotics with antibiofilm activity - rifampicin and beyond.

Autor: Ferreira L; Department of Infectious Diseases, Centro Hospitalar e Universitário de Santo António, Porto, Portugal., Pos E; Department of Infectious Diseases, Centro Hospitalar e Universitário de Santo António, Porto, Portugal., Nogueira DR; Department of Infectious Diseases, Centro Hospitalar e Universitário de Santo António, Porto, Portugal., Ferreira FP; Department of Infectious Diseases, Centro Hospitalar e Universitário de Santo António, Porto, Portugal., Sousa R; Department of Orthopaedic Surgery, Centro Hospitalar e Universitário de Santo António, Porto, Portugal.; Grupo de Infeção Osteoarticular do Porto, Porto, Portugal., Abreu MA; Department of Infectious Diseases, Centro Hospitalar e Universitário de Santo António, Porto, Portugal.; Grupo de Infeção Osteoarticular do Porto, Porto, Portugal.

Publikováno v: Frontiers in microbiology [Front Microbiol] 2024 Aug 29; Vol. 15, pp. 1435720. Date of Electronic Publication: 2024 Aug 29 (Print Publication: 2024).

Individuals with type 2 diabetes have higher density of small intestinal neurotensin-expressing cells.

Autor: Ferreira FP; Department of Anatomy, UMIB-Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), University of Porto, Rua Jorge Viterbo Ferreira 228, Building 1.3, 4050-313, Porto, Portugal.; ITR-Laboratory for Integrative and Translational Research in Population Health, Porto, Portugal., Pereira SS; Department of Anatomy, UMIB-Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), University of Porto, Rua Jorge Viterbo Ferreira 228, Building 1.3, 4050-313, Porto, Portugal. sspereira@icbas.up.pt.; ITR-Laboratory for Integrative and Translational Research in Population Health, Porto, Portugal. sspereira@icbas.up.pt., Costa MM; Department of Anatomy, UMIB-Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), University of Porto, Rua Jorge Viterbo Ferreira 228, Building 1.3, 4050-313, Porto, Portugal.; ITR-Laboratory for Integrative and Translational Research in Population Health, Porto, Portugal., Guimarães M; Department of Anatomy, UMIB-Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), University of Porto, Rua Jorge Viterbo Ferreira 228, Building 1.3, 4050-313, Porto, Portugal.; ITR-Laboratory for Integrative and Translational Research in Population Health, Porto, Portugal.; Department of General Surgery, Centro Hospitalar de Entre Douro E Vouga, Santa Maria da Feira, Portugal., Albrechtsen NJW; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, 2100, Copenhagen, Denmark.; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark., Holst JJ; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, 2100, Copenhagen, Denmark., Nora M; Department of General Surgery, Centro Hospitalar de Entre Douro E Vouga, Santa Maria da Feira, Portugal., Monteiro MP; Department of Anatomy, UMIB-Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), University of Porto, Rua Jorge Viterbo Ferreira 228, Building 1.3, 4050-313, Porto, Portugal.; ITR-Laboratory for Integrative and Translational Research in Population Health, Porto, Portugal.

Publikováno v: Molecular and cellular biochemistry [Mol Cell Biochem] 2023 Dec; Vol. 478 (12), pp. 2779-2787. Date of Electronic Publication: 2023 Mar 15.